COVID-19 treatment: Randomised drug trials to be available in early July

30

London: The first results from world’s largest randomised drug trials is expected to be available in early July, according to UK based scientists.

The first data from the study, which is testing a selection of existing drugs, is likely to come from a type of steroid called low-dose Dexamethasone.

The trial has so far enrolled 11,000 patients ranging from one to 109 years of ages at 175 UK hospitals since it was set up in March, according to reports.

Other medicines being tested are the anti-malaria drug hydroxychloroquine, Lopinavir-Ritonavir, which is used to treat HIV, an antibiotic called Azithromycin and convalescent plasma, which is collected from people who have recovered from the virus and contains antibodies against it.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.